healthcare.digital May 25, 2024
Health Tech founder and M&A Advisor Lloyd Price shares his thoughts with Pharmaceutical Market Europe about Clinical Trials and Diversity challenges.
“Price sees a well of digital approaches that could energise trial enrolment among under-represented communities and boost retention.
But he cautions: “It’s important to remember that technology is a tool, and its success hinges on its implementation alongside culturally sensitive practices and a genuine commitment to diversity within the research community.
By making trials more accessible, culturally sensitive and transparent, technology can pave the way for more inclusive research and ultimately, better healthcare outcomes for everyone.
‘Results from a poll of 2,000 people reveal respondents have significant trust in vaccines and prescription drugs but less trust in...
Today's Sponsors
Today's Sponsor